Chargement en cours...
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
A number of monoclonal antibodies (mAb) are now under investigation in clinical trials to assess their potential role in Systemic Lupus Erythematosus (SLE). The most frequently used mAb is rituximab, which is directed against CD20, a membrane protein expressed on B lymphocytes. Uncontrolled trials r...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Molecular Diversity Preservation International
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3991031/ https://ncbi.nlm.nih.gov/pubmed/27713252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph3010300 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|